Table 2.

Difference in social and role functioning between CHR converters and nonconverters per age band

GF	B	SE	Z	p	CI 95%
Social
12–15	−0.55	0.47	−1.18	.240	[−1.47, 0.37]
15–18	−0.83	0.25	−3.33	.001	[−1.32, −0.34]
18–21	−0.68	0.28	−2.41	.02	[−1.23, −0.13]
21–23	−1.53	0.38	−4.01	<.0001	[−2.27, −0.78]
Role
12–15	−1.60	0.55	−2.91	.004	[−2.69, −0.52]
15–18	−0.43	0.32	−1.36	.173	[−1.05, 0.189]
18–21	−0.64	0.32	−1.98	.048	[−1.26, −0.007]
21–23	−0.98	0.37	−2.68	.007	[−0.07, −0.26]

Note: CHR, Clinical high risk; GF, global functioning. All analyses are controlled for IQ and gender. Number of data points: 12–15 years: CHR converters (CHR-C), n = 25; CHR nonconverters (CHR-NC), n = 228; 15–18 years: CHR-C, n = 76; CHR-NC, n = 377; 18–21 years: CHR-C, n = 86; CHR-NC, n = 251; 21–23 years: CHR-C, n = 27; CHR-NC, n = 125.